These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

310 related articles for article (PubMed ID: 27307471)

  • 1. The anticoagulation choices of internal medicine residents for stroke prevention in non-valvular atrial fibrillation.
    Moulson N; McIntyre WF; Oqab Z; Yazdan-Ashoori P; Quinn KL; van Oosten E; Hopman WM; Baranchuk A
    Postgrad Med J; 2017 Jun; 93(1100):308-312. PubMed ID: 27307471
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Resident Physicians Choices of Anticoagulation for Stroke Prevention in Patients With Nonvalvular Atrial Fibrillation.
    Oqab Z; McIntyre WF; Quinn KL; Lamb T; Quadros K; Yazdan-Ashoori P; van Oosten E; Chu K; Lamba J; Barake W; Mohajer K; Marr JN; Baranchuk A
    Can J Cardiol; 2016 Jun; 32(6):824-8. PubMed ID: 26652126
    [TBL] [Abstract][Full Text] [Related]  

  • 3. How do family medicine residents choose an anticoagulation regimen for patients with nonvalvular atrial fibrillation?
    Yazdan-Ashoori P; Oqab Z; McIntyre WF; Quinn KL; Oosten EV; Hopman WM; Baranchuk A
    Prim Health Care Res Dev; 2017 Sep; 18(5):472-481. PubMed ID: 28464979
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identifying Factors That Predict the Prescription of Non-vitamin K Antagonist Oral Anticoagulants in Older Individuals With Atrial Fibrillation.
    Shurrab M; Ko DT; McElhaney J; Henderson M; Danon A; Quinn KL; O'Donnell D; Crystal E; Newman D
    J Am Med Dir Assoc; 2019 Aug; 20(8):984-987. PubMed ID: 30853427
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The health care setting rather than medical speciality impacts on physicians adherence to guideline-conform anticoagulation in outpatients with non-valvular atrial fibrillation: a cross sectional survey.
    Gerber B; Stussi G; Rosemann T; Senn O
    BMC Cardiovasc Disord; 2012 Feb; 12():12. PubMed ID: 22376271
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Trends in Prescribing Oral Anticoagulants in Canada, 2008-2014.
    Weitz JI; Semchuk W; Turpie AG; Fisher WD; Kong C; Ciaccia A; Cairns JA
    Clin Ther; 2015 Nov; 37(11):2506-2514.e4. PubMed ID: 26481493
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The management of non-valvular atrial fibrillation (NVAF) in Australian general practice: bridging the evidence-practice gap. A national, representative postal survey.
    Gattellari M; Worthington JM; Zwar NA; Middleton S
    BMC Fam Pract; 2008 Nov; 9():62. PubMed ID: 19014560
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Therapy persistence in newly diagnosed non-valvular atrial fibrillation treated with warfarin or NOAC. A cohort study.
    Martinez C; Katholing A; Wallenhorst C; Freedman SB
    Thromb Haemost; 2016 Jan; 115(1):31-9. PubMed ID: 26246112
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Use of non-vitamin K antagonist oral anticoagulants in atrial fibrillation patients: insights from a specialist atrial fibrillation clinic.
    Lee SI; Sayers M; Lip GY; Lane DA
    Int J Clin Pract; 2015 Nov; 69(11):1341-8. PubMed ID: 26234557
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prescription Patterns of Non-Vitamin K Oral Anticoagulants Across Indications and Factors Associated with Their Increased Prescribing in Atrial Fibrillation Between 2012-2015: A Study from the Norwegian Prescription Database.
    Urbaniak AM; Strøm BO; Krontveit R; Svanqvist KH
    Drugs Aging; 2017 Aug; 34(8):635-645. PubMed ID: 28710707
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prescription patterns of oral anticoagulants for patients with non-valvular atrial fibrillation: experience at a Japanese single institution.
    Tagaya M; Yoshikawa D; Sugishita Y; Yamauchi F; Ito T; Kamada T; Yoshinaga M; Mukaide D; Fujiwara W; Yokoi H; Hayashi M; Watanabe E; Ishii J; Ozaki Y; Izawa H
    Heart Vessels; 2016 Jun; 31(6):957-62. PubMed ID: 26022376
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Current status and factors influencing oral anticoagulant therapy among patients with non-valvular atrial fibrillation in Jiangsu province, China: a multi-center, cross-sectional study.
    Liu T; Yang HL; Gu L; Hui J; Omorogieva O; Ren MX; Wang XH
    BMC Cardiovasc Disord; 2020 Jan; 20(1):22. PubMed ID: 31948390
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Characteristics affecting oral anticoagulant therapy choice among patients with non-valvular atrial fibrillation: a retrospective claims analysis.
    AbuDagga A; Stephenson JJ; Fu AC; Kwong WJ; Tan H; Weintraub WS
    BMC Health Serv Res; 2014 Jul; 14():310. PubMed ID: 25034699
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Medical costs in the US of clinical events associated with oral anticoagulant (OAC) use compared to warfarin among non-valvular atrial fibrillation patients ≥75 and <75 years of age, based on the ARISTOTLE, RE-LY, and ROCKET-AF trials.
    Deitelzweig S; Amin A; Jing Y; Makenbaeva D; Wiederkehr D; Lin J; Graham J
    J Med Econ; 2013 Sep; 16(9):1163-8. PubMed ID: 23869941
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Consideration of clinical variables for choosing new anticoagulant alternatives to warfarin for the management of non-valvular atrial fibrillation.
    Lu Y; Branstad R; Karim RM; Asinger RW
    J Clin Pharm Ther; 2014 Dec; 39(6):628-36. PubMed ID: 25252149
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Safety and efficacy of non-vitamin K oral anticoagulant treatment compared with warfarin in patients with non-valvular atrial fibrillation who develop acute ischemic stroke or transient ischemic attack: a multicenter prospective cohort study (daVinci study).
    Saji N; Kimura K; Tateishi Y; Fujimoto S; Kaneko N; Urabe T; Tsujino A; Iguchi Y;
    J Thromb Thrombolysis; 2016 Nov; 42(4):453-62. PubMed ID: 27207691
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Profiling of patients with non-valvular atrial fibrillation and moderate-to-high risk of stroke not receiving oral anticoagulation in Spain.
    Polo García J; Vargas Ortega D; Formiga F; Unzueta I; Fernández de Cabo S; Chaves J
    Semergen; 2019 Sep; 45(6):396-405. PubMed ID: 30573367
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Treatment and persistence with oral anticoagulants among newly diagnosed patients with non-valvular atrial fibrillation: a retrospective observational study in a US commercially insured and Medicare Advantage population.
    Willey V; Franchino-Elder J; Fu AC; Wang C; Sander S; Tan H; Kraft E; Jain R
    BMJ Open; 2018 Jun; 8(6):e020676. PubMed ID: 29961012
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antithrombotic treatment and characteristics of elderly patients with non-valvular atrial fibrillation hospitalized at Internal Medicine departments. NONAVASC registry.
    Gullón A; Suárez C; Díez-Manglano J; Formiga F; Cepeda JM; Pose A; Camafort M; Castiella J; Rovira E; Mostaza JM;
    Med Clin (Barc); 2017 Mar; 148(5):204-210. PubMed ID: 27993408
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Use of oral anticoagulants in atrial fibrillation is highly variable and only weakly associated with estimated stroke risk: cross-sectional population database study.
    Dreischulte T; Barnett K; Madhok V; Guthrie B
    Eur J Gen Pract; 2014 Sep; 20(3):181-9. PubMed ID: 24351017
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.